OClawVPS.com
Xsensio
Edit

Xsensio

http://www.xsensio.com/
Last activity: 05.03.2026
Active
Categories: BiosensorsBiotechDeepTechHealthcareWearables
Xsensio is a Swiss digital-health company, which develops the unique Lab-on-Skin™​ sensing platform for next-gen wearables. It senses in real-time biochemical information at the surface of the skin, providing unprecedented real-time information about our health and wellness, in a simple and non-invasive way.

Xsensio is a B2B company, offering Lab-on-Skin™ solutions to consumer care and consumer electronics companies.
Followers
265
Followers
1.99K
Website visits
2.6K /mo.
Mentions
49
Location: Switzerland
Employees: 11-50
Total raised: $11.59M
Founded date: 2014

Investors 6

Funding Rounds 2

DateSeriesAmountInvestors
03.03.2026Series A$7.02MEuropean I...
17.12.2021-$4.57M-

Mentions in press and media 49

DateTitleDescription
05.03.2026Xsensio Secures $7M to Propel Real-Time Wearable Biosensing into Clinical PracticeXsensio secured $7M Series A funding. This investment propels its innovative "Lab-on-Skin" wearable biosensing platform forward. The system delivers continuous, real-time biochemical data directly from the body. It monitors crucia...
05.03.2026Behavioral Health Transformed: Ease Health Secures $41M for AI-Native SystemEase Health secured $41 million in Series A funding. Andreessen Horowitz led the investment. This capital infusion fuels the company's mission. Ease Health builds an AI-native operating system for behavioral health providers. It unifies CRM...
03.03.2026Xsensio’s wearable chip that analyses proteins and hormones in real time draws €6 millionXsensio, a Lausanne-based DeepTech company developing near real-time continuous biochemical monitoring, announced the successful closing of a €6 million ($7 million) oversubscribed Series A financing round. The round was led by VC firm WI H...
02.03.2026Oversubscribed $7M Series A to boost Xsensio biosensing clinical deployment Xsensio develops the Lab-on-Skin wearable biosensing platform to deliver continuous, real-time biochemical information for personalized and preventive healthcare. Designed for multiparametric analysis, its ultra-miniaturized chip integrate...
02.03.2026Ease Health Raises $41M in Series A FundingEase Health, a NYC-based provider of an AI-native CRM, EHR, and RCM platform, raised $41M in Series A funding. The round was led by Andreessen Horowitz The company intends to use the funds to expand its product and engineering teams, accele...
19.06.2023TechTour Growth Health showcases Swiss health solutions
01.02.2023Xsensio attracts Mayo Clinic as partner and investor
20.12.2021Xsensio raises CHF 4.2 million to expand development of proprietary platform and accelerate market launchXsensio raises CHF 4.2 million to expand development of proprietary platform and accelerate market launch 20.12.2021 15:41, Isabelle Mitchell linkedIn facebook twitter instagram youtube --> Xsensio, a company in the emerging field of wea...
20.12.2021Xsensio raises CHF 4.2 million to expand development of proprietary platform and accelerate market launchThe investment round is led by Privilège Ventures, a Swiss venture capital firm with offices in Lugano, Zurich, and Boston, and included the EIC Fund and other international investors. The proceeds will be used to expand product and platfor...
17.12.2021Xsensio raises CHF 4.2 million to accelerate market launch
Show more

Reviews 0

Sign up to leave a review

Sign up Log In